- ROUNDTABLE: Pharmacy’s future in sync with technology
- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- President Obama addresses health reform during State of the Union, industry responds
- CVS' Merlo: Health reform to benefit business in 2014
- Bloomberg: Greg Wasson joins thought leaders to discuss the state of health care in the United States
NEW YORK — Coty Inc., an emerging global leader in beauty, announced today that it has added Olivier Goudet , partner and chief executive officer of the Joh. A. Benckiser Group, to the company's board of directors.
Goudet replaces Bernd Beetz, who stepped down from Coty's Board to pursue other interests. JAB is a privately held group that owns and invests in premium brands; it is also Coty's majority shareholder.
"We bid Bernd a fond farewell and wish him the best of luck in his new endeavors. Coty, its employees and shareholders will be forever grateful for Bernd's leadership during his tenure as Coty's CEO. We will miss his passion, energy and the many contributions he made to the Coty business throughout well over a decade," said Bart Becht, chairman, Coty's board of directors. "We are excited to add Olivier's enormous talents and expertise to our board, and look forward to drawing on his wealth of knowledge and business experience, particularly with publicly traded consumer companies."
Mr. Beetz remarked, "As I step down from Coty's Board and look back upon my past 11 years at Coty, I am proud to have been at the helm during this time in Coty's history. I am full of enthusiasm as I begin a new chapter in my professional life, and wish everyone at Coty continued success!"
In addition to Mr. Goudet's role with JAB, he also serves on the board of directors of Anheuser-Busch InBev and the board of the Washington Performing Arts Society. Prior to joining JAB, Mr. Goudet was chief financial officer of Mars Inc.
Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.